Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

A Focus on Clinical Research

HDx

The real-life study on expanded hemodialysis (HDx): 9 months experience of a single hemodialysis unit

View resource
HDx

Protein loss and medium cut-off haemodialysis

View resource
HDx

Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up - Schepers E, et al.

View resource
HDx

Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules - Belmouaz M, et al.

View resource
HDx

Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration - García-Prieto A, et al.

View resource
HDx

Expanded Hemodialysis - A step closer to natural kidneys - Ronco C, et al.

View resource
HDx

Hypoalbuminemia: a price worth paying for improved dialytic removal of middle-molecular-weight uremic toxins? - Ward RA, et al.

View resource
HDx

Is Expanded Hemodialysis an Option to Online Hemodiafiltration for Small- and Middle-Sized Molecules Clearance? - Reque J et al.

View resource
HDx

A Global Study Assessing Albumin Levels on Expanded Hemodialysis

View resource
HDx

Evaluation of Albumin Loss During Hemodialysis with Theranova® Medium Cut-Off (MCO) Dialyzer: Six Months Follow-Up

View resource
HDx

Current approaches to middle molecule removal: room for innovation

View resource
HDx

Cardiovascular disease in dialysis patients

View resource